about
[Melasma : An update on the clinical picture, treatment, and prevention].Natural options for the management of hyperpigmentation.Treatment of melasma with topical agents, peels and lasers: an evidence-based review.Facial hyperpigmentation: causes and treatment.Facial primer provides immediate and long-term improvements in mild-to-moderate facial hyperpigmentation and fine lines associated with photoaging.On the role of skin in the regulation of local and systemic steroidogenic activities.Role of the steroidogenic acute regulatory protein in health and disease.An integral topical gel for cellulite reduction: results from a double-blind, randomized, placebo-controlled evaluation of efficacy.Overview of skin whitening agents with an insight into the illegal cosmetic market in Europe.Skin-lightening effects of a new face care product in patients with melasma.Facial skin-lightening benefits of the tetrapeptide Pro-Lys-Glu-Lys on subjects with skin types V-VI living in South Africa.The Inhibitory Effect of Phytoclear-EL1 on Melanogenesis.Long-term Multi-product Facial Regimen in Subjects with Moderate-to-severe Photodamage and Hyperpigmentation.A novel anti-ageing mechanism for retinol: induction of dermal elastin synthesis and elastin fibre formation.Treatment options in insulin resistance obesity-related acanthosis nigricans.Anti-pigmentary activity of fucoxanthin and its influence on skin mRNA expression of melanogenic molecules.Retinyl propionate and climbazole combination demonstrates clinical improvement to the appearance of hyperpigmentation and deep wrinkling with minimal irritation.β-Cryptoxanthin suppresses UVB-induced melanogenesis in mouse: involvement of the inhibition of prostaglandin E2 and melanocyte-stimulating hormone pathways.Voriconazole-induced photosensitivity: photobiological assessment of a case series of 12 patients.Lentigos, Melanocytic Naevi and Melanoma
P2860
Q30239038-0A89E67E-AB2E-4BA4-8C62-5D698620F9AAQ34188297-811DFF5A-EEE4-4454-A6D0-2093A894F172Q34359554-CCBE8C88-5828-43FB-BF46-C5DBA70D2319Q35010478-9BB86134-AE8A-4413-BDE1-1B94E4C35AA7Q36036960-5CE3C86E-5BFD-4921-A333-51E116971163Q36244943-810F2802-C00C-4D6F-AB40-8400D677474FQ36447481-1E1766DF-8F99-4D2A-B846-6544480DE9B5Q37600489-EAE5DCE4-30BA-4A94-8284-943DC73A024BQ38765044-9A15F972-3052-441E-BDE7-DD8F44EBE340Q39832928-7FACFFFC-24F6-4EC7-8062-469FF4EADD2FQ39997710-48C5D492-AE05-49F4-8969-357909D947CCQ40249854-75CE9870-5326-4C20-A94A-51D886A2128BQ40311152-CFCF07C2-4A47-4570-8EF1-2F9ECE8BC6E8Q43511451-5D34C02B-04D5-4015-B9FA-076027CF9D95Q46156535-F451BC59-3708-45DB-A976-8E1E3162C2B6Q46389116-2449328D-9012-4547-A946-A2FE46695BE2Q48362717-5BC3CD03-AC41-45F9-AF42-E1A6DD778922Q53158352-53038D1B-3373-4027-AECB-AF8DBCE744DBQ53266683-001DA273-A7A7-4EE8-80FD-8FCD0D33824DQ56828381-E28E9AC1-50C9-4E90-B8C6-0DCB69F0509C
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Retinoid therapy of pigmentary disorders.
@ast
Retinoid therapy of pigmentary disorders.
@en
type
label
Retinoid therapy of pigmentary disorders.
@ast
Retinoid therapy of pigmentary disorders.
@en
prefLabel
Retinoid therapy of pigmentary disorders.
@ast
Retinoid therapy of pigmentary disorders.
@en
P2860
P1433
P1476
Retinoid therapy of pigmentary disorders.
@en
P2093
Jean-Paul Ortonne
P2860
P304
P356
10.1111/J.1529-8019.2006.00085.X
P577
2006-09-01T00:00:00Z